Aeterna Zentaris Inc. Common Stock, a biopharmaceutical company, focuses on developing and commercializing therapies for cancer and other diseases. The company’s product portfolio includes drugs for the treatment of endometrial cancer, prostate cancer, and cancer-related cachexia. With a commitment to innovation, Aeterna Zentaris aims to make a meaningful impact on the lives of patients worldwide.
